Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FAAH | O00519 | 8/20 | 0.36 |
| ▸ | CES1 | P23141 | 6/20 | 0.34 |
| ▸ | CES2 | O00748 | 3/20 | 0.34 |
| ▸ | MEN1 | O00255 | 1/20 | 0.34 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.34 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.34 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.34 |
| ▸ | FFAR3 | O14843 | 1/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.32 |
| ▸ | TSHR | P16473 | 1/20 | 0.32 |
| ▸ | FUCA1 | P04066 | 1/20 | 0.32 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.31 |
| ▸ | ACLY | P53396 | 2/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Trifluoroacetic Acid SCHEMBL5494627 | 0.97 | FAAH (0.34) | FAAHCES1CES2MEN1CYP1A2 | |
| Trifluoroacetic Acid SCHEMBL60804 | 0.93 | FAAH (0.32) | FAAHCES1CES2MEN1CYP1A2 | |
| Trifluoroacetic Acid SCHEMBL28246387 | 0.91 | FAAH (0.31) | FAAHCES1CES2MEN1CYP1A2 | |
| Trifluoroacetic Acid SCHEMBL8181430 | 0.89 | DPP8 (0.32) | FAAH | |
| Trifluoroacetic Acid SCHEMBL27841664 | 0.82 | FAAH (0.42) | FAAHCES1CES2MEN1CYP1A2 | |
| Trifluoroacetic Acid SCHEMBL31031817 | 0.82 | FAAH (0.42) | FAAHCES1CES2MEN1CYP1A2 | |
| Trifluoroacetic Acid SCHEMBL3794549 | 0.79 | FAAH (0.40) | FAAHCES1CES2MEN1CYP1A2 | |
| Trifluoroacetic Acid SCHEMBL281599 | 0.79 | FAAH (0.40) | FAAHCES1CES2MEN1CYP1A2 | |
| Trifluoroacetic Acid SCHEMBL15711042 | 0.79 | FAAH (0.46) | FAAHCES1CES2MEN1CYP1A2 | |
| Trifluoroacetic Acid SCHEMBL30324569 | 0.79 | FAAH (0.40) | FAAHCES1CES2MEN1CYP1A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 379 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117820309-A | Piperazinyl-heterocyclic compound and application thereof | 江苏恩华药业股份有限公司 | 2024-04-05 | — | — | CN | claimed |
| CN-112154140-B | Compound and application thereof in synthesizing Brivaracetam (Brivaracetam) bulk drug | 福建海西新药创制股份有限公司 | 2023-11-24 | — | — | CN | claimed |
| CN-111961006-B | Method for synthesizing intermediate of trilithiotinib triazole | 同济大学 | 2023-03-28 | — | — | CN | claimed |
| CN-112279804-A | Method for preparing 2-chloro-4-neopentyl pyridine | 上海凌凯医药科技有限公司 | 2021-01-29 | — | — | CN | claimed |
| CN-112154140-A | Compound and application thereof in synthesizing bulk drug of Brivaracetam (Brivaracetam) | 福建海西新药创制有限公司 | 2020-12-29 | — | — | CN | claimed |
| CN-111961006-A | Method for synthesizing intermediate of trilithiotinib triazole | 同济大学 | 2020-11-20 | — | — | CN | claimed |
| WO-2020143674-A1 | COMPOUNDS AND THEIR USE IN THE SYNTHESIS OF BRIVARACETAM APIS | FUJIAN HAIXI PHARMACEUTICALS CO., LTD (CN) | 2020-07-16 | — | — | WO | claimed |
| CN-105384619-B | Isopropyl phenol derivative and preparation method thereof | 四川海思科制药有限公司 | 2020-05-29 | — | — | CN | claimed |
| CN-105384607-B | A kind of cumene amphyl and preparation method thereof | 四川海思科制药有限公司 | 2019-08-16 | — | — | CN | claimed |
| CN-105384604-B | A kind of cumene amphyl and preparation method thereof | 四川海思科制药有限公司 | 2019-07-05 | — | — | CN | claimed |
| CN-107056730-B | A kind of synthetic method and its application of bupropion hydrochloride sustained release tablets impurity isomers | 浙江普洛家园药业有限公司 | 2019-05-24 | — | — | CN | claimed |
| EP-2282991-B1 | METHOD FOR THE PRODUCTION OF 1,4-BENZOTHIEPIN-1,1-DIOXIDE DERIVATIVES | SANOFI AVENTIS DEUTSCHLAND (DE) | 2018-01-24 | — | — | EP | claimed |
| US-8461312-B2 | Method for the production of 1,4-benzothiepin-1,1-dioxide derivatives | SANOFI (FR) | 2013-06-11 | — | — | US | claimed |
| WO-2012147107-A2 | NOVEL & IMPROVED PROCESSES FOR THE PREPARATION OF INDOLINE DERIVATIVES AND ITS PHARMACEUTICAL COMPOSITION | MSN LABORATORIES LIMITED (IN) | 2012-11-01 | — | — | WO | claimed |
| US-20110245486-A1 | METHOD FOR THE PRODUCTION OF 1,4-BENZOTHIEPIN-1,1-DIOXIDE DERIVATIVES | SANOFI-AVENTIS DEUTSCHLAND GMBH (DE) | 2011-10-06 | — | — | US | claimed |
| US-4535167-A | CONDENSATION OF ACID AND ALDEHYDE FOLLOWED BY REDUCTIVE CLEAVAGE OF OXAZOLIDINONE INTERMEDIATE | MERCK & CO. INC. (US) | 1985-08-13 | — | — | US | claimed |
| EP-4630403-A1 | COMPOUNDS FOR THE TREATMENT OF NEUROMUSCULAR DISORDERS | NMD Pharma A/S (DK) | 2025-10-15 | — | — | EP | disclosed |
| WO-2024121129-A1 | COMPOUNDS FOR THE TREATMENT OF NEUROMUSCULAR DISORDERS | NMD PHARMA A/S (DK) | 2024-06-13 | — | — | WO | disclosed |
| US-4448990-A | Hydroxyaminotetralincarboxamides | ELI LILLY AND COMPANY (US) | 1984-05-15 | — | — | US | disclosed |
| US-4054740-A | Hydroxybiotin | HOFFMANN-LA ROCHE INC. (US) | 1977-10-18 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110245486-A1 | METHOD FOR THE PRODUCTION OF 1,4-BENZOTHIEPIN-1,1-DIOXIDE DERIVATIVES | BBOX1, SULT1E1, PTGS1 | FAAH 1416/4885CES1 205/4885CES2 1116/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.